Join the Oncology Voice Network. Join for Free
Mastering the Medical Affairs Professional Role: Inside and Out
Medical Science Liaison Key Opinion Leader MSL Career Transition Medical Affairs Strategies Effective KOL Engagement

Mastering the Medical Affairs Professional Role: Inside and Out


Share This Article


Summary

In this episode, Tom Caravela welcomes Kent Christofferson to discuss his career journey and insights into the MSL role. Kent shares his transition from academia to industry, highlighting the importance of mastering the MSL role and thinking like a Key Opinion Leader (KOL). He delves into the value proposition of MSLs, the significance of team effectiveness, and the challenges of handling multiple roles. The conversation covers compliance, technology, and future medical affairs directions, emphasizing digital engagement and the shift towards relationship-based interactions. Kent concludes with strategies for effective KOL engagement and the importance of leadership support in the evolving MSL landscape.

Kent Christopherson, Senior  Director, Medical Affairs at Orchard Therapeutics discusses the art of Mastering the Medical Affairs Professional Role Internally and Externally.

Kent shares…

πŸ‘‰ Why MSLs need to “think like a KOL”

πŸ‘‰ The importance of Individual Development Plans

πŸ‘‰ Integrated Team Effectiveness Model- (ITEM) ref: 2006, Louise Lemieux-Charles, Wendy L McGuire

πŸ‘‰ Why clinical insights is the currency for MSL value internally

πŸ‘‰ Why it is vital to understand what KOLs motivation is in order to ensure value and meet deliverables

Click for Source
Medical Science Liaison, Key Opinion Leader, MSL Career Transition, Medical Affairs Strategies, Effective KOL Engagement

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Article
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
OVN Avatar Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Explore OVN